Adagio Therapeutics’ $356 Million Initial Public Offering

Martina Bellini North America, North America Legal Chronicle
Tagged:

Davis Polk advised the representatives of the several underwriters in the offering.Adagio Therapeutics, Inc. executed the initial public offering of 20,930,000 shares of its common stock at $17.00…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here